Management Team

Olivier Morand

Olivier Morand

Chief Executive Officer and Executive Board Member

Senior leader in pharma strategic development

Kyle Landskroner

Kyle Landskroner

Head of Preclinical Drug Development

Seasoned expert in early-stage drug discovery & development

Ruben Giorgino

Ruben Giorgino

Head of Clinical Research and Development

Well-versed leader in global clinical R&D

Louise Kooij

Louise Kooij

Head of Finance and Operations

International financial and commercial pharma strategist

Board of Directors

Carlo Incerti

Carlo Incerti

Chairman and Non-Executive Board Member

Operating Partner at Forbion Capital Partners

Vanessa King

Vanessa King

Non-Executive Board Member

Venture Partner at Abingworth, LLP

Sander Slootweg

Sander Slootweg

Non-Executive Board Member

Managing Partner at Forbion

Olivier Morand

Olivier Morand

Chief Executive Officer and Executive Board Member

Senior leader in pharma strategic development

Edward van Wezel

Edward van Wezel

Executive Board Member

Founder and Managing Partner at BioGeneration Ventures

Andreas Wallnöfer

Andreas Wallnöfer

Non-Executive Board Member

General Partner at BioMedPartners